Autophagy regulates cell death both positively and negatively, but the molecular basis for this paradox remains inadequately characterized. We demonstrate here that transient cell-to-cell variations in autophagy can promote either cell death or survival depending on the stimulus and cell type. By separating cells with high and low basal autophagy using flow cytometry, we demonstrate that autophagy determines which cells live or die in response to death receptor activation. We have determined that selective autophagic degradation of the phosphatase Fap-1 promotes Fas apoptosis in Type I cells, which do not require mitochondrial permeabilization for efficient apoptosis. Conversely, autophagy inhibits apoptosis in Type II cells (which require mitochondrial involvement) or on treatment with TRAIL in either Type I or II cells. These data illustrate that differences in autophagy in a cell population determine cell fate in a stimulus-and cell-type-specific manner. This example of selective autophagy of an apoptosis regulator may represent a general mechanism for context-specific regulation of cell fate by autophagy.
Autophagy regulates cell death both positively and negatively, but the molecular basis for this paradox remains inadequately characterized. We demonstrate here that transient cell-to-cell variations in autophagy can promote either cell death or survival depending on the stimulus and cell type. By separating cells with high and low basal autophagy using flow cytometry, we demonstrate that autophagy determines which cells live or die in response to death receptor activation. We have determined that selective autophagic degradation of the phosphatase Fap-1 promotes Fas apoptosis in Type I cells, which do not require mitochondrial permeabilization for efficient apoptosis. Conversely, autophagy inhibits apoptosis in Type II cells (which require mitochondrial involvement) or on treatment with TRAIL in either Type I or II cells. These data illustrate that differences in autophagy in a cell population determine cell fate in a stimulus-and cell-type-specific manner. This example of selective autophagy of an apoptosis regulator may represent a general mechanism for context-specific regulation of cell fate by autophagy.
Macroautophagy (hereafter autophagy) is a catabolic process that facilitates cell survival in response to stress by providing nutrients and biosynthetic monomers, and by mitigating cellular damage 1, 2 . Several studies have suggested that autophagy is capable of regulating apoptosis but, surprisingly, autophagy can both promote or inhibit cell death in different cellular contexts 3, 4 . The molecular underpinnings of this duality remain poorly defined despite the fact that they have important implications in human disease [5] [6] [7] . Despite many links between specific proteins of the autophagy and apoptosis pathways, surprisingly little is known about how the overall process of autophagy determines whether cells live or die in response to cell death stimuli [8] [9] [10] [11] . Apoptosis is known to control autophagy (both positively and negatively) through molecular mechanisms that have been described [12] [13] [14] and many autophagy regulators also control the apoptotic apparatus [15] [16] [17] [18] . However, mechanisms responsible for the regulation of apoptosis by the overall process of autophagy are less clear [19] [20] [21] . Except in the case of salivary gland cell death in Drosophila 22 and the autophagic degradation of catalase 23 , precise mechanisms responsible for direct promotion of cell death by autophagy are unknown.
In populations of cells treated with apoptotic stimuli, some cells will escape death for reasons that have only recently been addressed but which have important clinical consequences, particularly in cancer therapy. Non-genetic heterogeneity, stochastic state differences 
Figure 1
Log-phase proliferating cells in optimal growth media exhibit significant steady-state differences in autophagic flux. (a,b) BJAB lymphoma cells stably expressing mCherry-GFP-LC3 were serially cultured at log phase followed by fluorescence-activated cell sorting for cells with high and low autophagic flux using the ratio of mCherry/GFP (a). The high and low 20% were sorted (a), re-plated and treated with lysosomal protease inhibitors pepstatin and E-64d for 1 h; lysates were then immunoblotted for the indicated proteins (b). (c) Densitometry of LC3-II and p62 western blots (normalized to actin and hour 0, mean ± s.e.m., n = 3 blots from 2 independent experiments, * P = 0.051, * * P = 0.0091). (d,e) HeLa mCherry-GFP-LC3 cells were sorted as in a, cytospun on to slides, fixed and visualized by confocal microscopy (d); autophagic LC3 puncta were assessed by quantitative microscopy (e; punctate area per cell, mean ± s.e.m., n = 50 fields, * P = 0.010, * * P = 0.053). (f) Electron micrographs of HeLa mCherry-GFP-LC3 cells sorted for autophagic flux as in a. Yellow arrows denote autophagosomes; red arrows indicate autolysosomes. (g) Quantification of autophagosomes and autolysomes from electron micrographs (mean ± s.e.m., n = 50 fields). Uncropped images of blots are shown in Supplementary Fig. 6 . quantify stochastic differences in basal autophagy in a cell population and determine the role of these differences in basal autophagy on cell death in response to specific apoptotic stimuli. To accomplish this, we used flow cytometry to sort cells on the basis of their relative levels of autophagic flux using mCherry-EGFP-LC3 as a reporter 29 ( Supplementary Fig. 1a ). This reporter for autophagic flux takes advantage of the higher sensitivity of EGFP fluorescence to the acidic environment of the autolysosome relative to mCherry (ref. 30): cells with higher flux are less green owing to autophagosome fusion with lysosomes, thereby increasing the mCherry/EGFP ratio ( Fig. 1a and Supplementary Fig. 1a,b) . This method to measure flux has been extensively validated and accurately quantifies autophagic flux induction by multiple stimuli and chemical and genetic inhibition of autophagy ( Fig. 1 and Supplementary Figs 1 and 2 ). To examine differences between high-and low-autophagic-flux cells under basal conditions, BJAB B-cell lymphoma cells were maintained near log phase in growth medium, collected and flow sorted into low-and high-flux populations (Fig. 1a) . Immunoblots for LC3 and p62 autophagy proteins confirmed the relative levels of flux present in the sorted cells (Fig. 1b,c) and quantification of autophagosomes and lysosomes by saponin extraction 31 followed by flow cytometry revealed substantial differences in the lysosome and autolysosome number between the high-and low-flux subpopulations ( Supplementary  Fig. 1d-f) . Furthermore, fluorescent and electron microscopy further substantiated that the cells differ in their levels of autophagic flux (Fig. 1d-g and Supplementary Fig. 2a,b) , and that these differences in flux were independent of cell size, cell cycle or spontaneous apoptosis (sub-G1 events; Supplementary Fig. 2c-f) . Importantly, we found that differences in basal flux were transient, persisting for at least 4 h after sorting but returning back to steady state by 24 h (Fig. 2a-c) ; this rapid reversion of the sorted cells indicates that genetic heterogeneity in the starting population was not responsible for differences in flux. Together, these data show that substantial differences in autophagic flux exist within cell populations, even under optimal growth conditions, probably due to transient stochastic fluctuations in the level or activity of key autophagy regulators.
Differences in basal autophagic flux dictate the apoptotic response
To establish whether cell-to-cell differences in basal autophagic flux control cell fate, we treated flow-sorted high-and low-autophagicflux populations with the death receptor agonists Fas ligand and TRAIL. BJAB cells with higher basal autophagic flux were more sensitive to Fas-ligand-induced apoptosis than low-flux cells (Fig. 2d,e and Supplementary Fig. 3a) . Surprisingly, this was not found with TRAIL treatment-high-and low-autophagy cells (sorted at the same time from the same population) tended towards the opposite in their sensitivity to TRAIL (Fig. 2d,e and Supplementary Cells were then re-plated and allowed to recover for 5 (Fas ligand) or 6 (TRAIL) days then assayed for viability (percentage of no ligand control, mean ± s.e.m., n = 3 wells, * P = 0.012). (f) BJAB mCherry-GFP-LC3 cells were sorted for autophagic flux as above and apoptosis was measured at 1 h by flow cytometry using AnnexinV and DAPI (mean ± s.e.m., n = 3 wells, * P = 0.0046). (g) Cells sorted as in a, were re-plated and, starting at the indicated times following sorting, treated with Fas ligand (4 ng ml −1 ) for 24 h; cell viability was then determined by MTS (percentage of untreated control, mean ± s.e.m., n = 3 wells). Uncropped images of blots are shown in Supplementary Fig. 6 . Fig. 3b ). Caspase-3/7 activity, AnnexinV staining and inhibition by the caspase inhibitor zVAD all indicated that the cell death we observed was apoptotic (not necrotic or autophagic) but independent of Bid ( Fig. 2f , Supplementary Figs 3c-f and 4a,b). Similar to the transience of high and low autophagic flux observed in sorted cells (Fig. 2a-c) , the differential response to Fas-induced apoptosis between sorted high-and low-flux populations persisted for 4-6 h and returned to steady state by 24 h (Fig. 2g) . These data indicate that transient differences in the level of basal autophagy between cells in a population determine the response to death receptor agonists. Furthermore, autophagy modulated apoptosis in opposing directions depending on the stimulus; high-autophagy cells were more sensitive to Fas-ligand-induced apoptosis but less sensitive to TRAIL, whereas low-autophagy cells showed the opposite. While the effect of autophagy on TRAIL-induced apoptosis was generally cytoprotective, the differences were less pronounced and consistent than those with Fas ligand.
Autophagy facilitates apoptosis in a stimulus-and cell-type-specific manner
Consistent with our results in sorted low-autophagy cells, pharmacologic and genetic inhibition of autophagy in BJAB cells resulted in increased viability on treatment with Fas ligand but not TRAIL or other cytotoxic drugs. To assess whether the effect of autophagy on Fig. 4f,g ). Together, these data show that autophagy is necessary for efficient cell killing by Fas ligand (but not TRAIL) in BJAB cells, but autophagy is dispensable for Fas-ligand-induced apoptosis in Jurkat cells and is dispensable for TRAIL-induced apoptosis in both cell types. Cells were then re-plated at low density and allowed to recover for 5-6 days, and then assayed for viability (percentage of no ligand control, mean ± s.e.m., n = 3 wells, * P = 0.0089). Atg7 knockdown data were not included for long-term viability owing to the growth suppressive effect of Atg7 knockdown in the absence of drug treatment. Uncropped images of blots are shown in Supplementary Fig. 6 .
Autophagy modulates Fas-induced death through the phosphatase Fap-1
The tyrosine phosphatase Fap-1 (Fas-associated phosphatase 1 or PTPN13, PTP-L1) specifically modulates Fas but not TRAIL signalling through dephosphorylation of Fas, which reduces its cell surface expression and activity [32] [33] [34] [35] . Fap-1 has been implicated in several cancers including liver cancer in which autophagy has been implicated as a tumour suppressor and Fas plays a major role in liver cell apoptosis [36] [37] [38] [39] . Fas-induced apoptosis can occur in two ways-with (Type II) or without (Type I) mitochondrial involvement [40] [41] [42] . Reduced Fap-1 expression in Type II cells is responsible (at least in part) for phenotypic differences between Fas Type I and Type II cells 39 . Flow-sorted low-autophagic-flux BJAB cells (Type I) exhibited higher Fap-1 levels than high-flux cells that correlated with higher cell viability (Fig. 4a,b) and increased Fas receptor at the cell surface ( Supplementary  Fig. 5a ). This was not seen in Jurkat cells (Type II), which express nearly undetectable levels of Fap-1 (ref. 43 ; Fig. 4a,b) . Type I SKW6.4 cells and Type II CEM-CCRF (CEM) cells exhibited a similar pattern of cell viability with autophagy inhibition and Fas ligand treatment as the BJAB and Jurkat cells (Fig. 4c,d ) and Fap-1 protein levels were substantially higher in the Type I cells than in the Type II cells (Fig. 4c) . When autophagy was blocked by chloroquine or shRNA knockdown of Atg5, Atg7 or Vps34, Fap-1 levels increased in the Type I cells, correlating with the reduced level of Fas-ligand-induced apoptosis (Fig. 4e,f) . No Fap-1 was detected with or without autophagy inhibition in the Type I Jurkat cells (Fig. 4c,f and Supplementary Fig. 5b ). Conversely, autophagy acted in a cytoprotective manner in Jurkat cells with autophagy gene knockdown leading to decreased viability in response to Fas ligand. Together, these data led us to reason that autophagy was modulating Fas apoptosis by selectively degrading Fap-1.
To determine the role of Fap-1 in autophagy modulation of autophagy, we sought to determine whether removal of Fap-1 could make BJAB cells respond to Fas ligand like Type II cells and whether exogenous expression of Fap-1 could make the Jurkat cells respond were transduced with control, Atg5, Atg7 or Vps34 shRNA lentiviruses, followed by three days of puromycin selection. Cells were then treated with Fas ligand (1.25 ng ml −1 ) or TRAIL (1.25 ng ml −1 ) for 24 h and viability was assessed by MTS (e; percentage of control (no ligand), mean ± s.e.m., n = 3 wells, * P = 1.4×10 −6 , * * P = 2.3×10 −5 , * * * P = 3.9×10 −5 , ğ P = 9.2×10 −6 , ğğ P = 3.4 × 10 −6 , ğğğ P = 1.7 × 10 −5 ). Immunoblots demonstrate Atg5, Atg7 and Vps34 knockdown, autophagy inhibition and altered Fap-1 levels. The blots are separated because different exposures were required to detect the proteins in one cell line without overexposing the lanes for the other; the Fap-1 blot is not separated to demonstrate the lack of Fap-1 protein in Type II Jurkat cells (f). Fap-1 blots (b,c,f) were run on separate gels owing to the quantity of protein required for detection (see Methods). Uncropped images of blots are shown in Supplementary Fig. 6 .
to Fas ligand like Type I cells. As predicted, overexpression of wild-type Fap-1 caused Jurkat cells to behave more like Type I cells in response to autophagy inhibition and Fas ligand, whereas expression of catalytically inactive ( CD) Fap-1 had no effect; wild-type or CD Fap-1 had no effect on the BJAB cells (Fig. 5a,b) . Conversely, Fap-1 shRNA knockdown abrogated the increase in cell death caused by chloroquine in response to Fas ligand in Type I BJAB cells (Fig. 5c-e and Supplementary Fig. 5c,d ) but did not have a substantial effect on TRAILinduced viability (Fig. 5c) . These results indicate that Fap-1 is necessary and sufficient for autophagy to modulate Fas-induced apoptosis.
Fap-1 is targeted for autophagic degradation through the selective autophagy adaptor p62
The adaptor protein p62 (also known as SQSTM1) and its family members regulate selective autophagy of specific cargoes 5, [44] [45] [46] [47] [48] . Furthermore, p62 associates with the death-inducing signalling complex (DISC) and modulates death receptor signalling 18, 44 . To determine whether Fap-1 autophagic degradation occurs through p62, we depleted p62 protein, which resulted in increased Fap-1 and concomitant inhibition of Fas-ligand-induced apoptosis (Fig. 6a,b) . We were also able to co-immunoprecipitate endogenous Fap-1 and p62 in a chloroquine and Fas-ligand-dependent manner (Fig. 6c, Supplementary Fig. 5e ). Therefore, p62 associates directly with Fap-1 enabling it to recruit Fap-1 for autophagic degradation in response to Fas receptor activation. Together, these data show that p62-mediated recruitment of Fap-1 to autophagosomes regulates the apoptotic response to Fas activation.
DISCUSSION
Our results demonstrate that transient and significant differences in autophagic flux are present at baseline in a popula- Immunoblots of lysates collected following chloroquine treatment. Long-term growth was assessed in cells from c by re-plating them at low density and allowing them to recover for 5 days, followed by viability assay (percentage of untreated control, mean ± s.e.m., n = 3 wells, * P = 0.043; e). Fap-1 blots (b,d) were run on separate gels owing to the quantity of protein required for detection (see Methods). Uncropped images of blots are shown in Supplementary  Fig. 6 . tion of actively proliferating cells. This cell-to-cell variability in autophagy leads to substantial differences in apoptosis induced by Fas ligand and TRAIL such that high-and low-autophagy cells from the same population exhibit opposing sensitivities to these two death ligands. These differences arise even under optimized cell culture conditions with clonally derived cells; we predict that such differences may be magnified in a more heterogeneous population of cells exposed to greater fluctuations in nutrients and environmental stresses that affect autophagy, such as those in a tumour.
Autophagy can thus determine which cells live and which cells die in a population but these effects are both stimulus-and cell-type-specific. Our work addresses an area that has been confusing-whether autophagy protects or kills cells 49 . Our data show that even in the same population of cells, it can do both and it is the context (that is, specific stimulus and cell type) that determines whether autophagy is pro-or anti-apoptotic. We do not know specifically or generally how autophagy is able to generally protect against apoptosis in our system, although it has been reported that autophagy can degrade activated caspase-8 to protect against TRAIL-induced death in other contexts 19 . However, our work does reveal a defined mechanism by which autophagy promotes apoptosis in mammalian cells. For Fas ligand, autophagy-dependent differences in apoptotic response depend on p62-mediated selective autophagic degradation of Fap-1 (Fig. 6d) . This model explains both the cell-type-specific differences whereby only Type I cells require autophagy for efficient apoptosis and the stimulus-specific effect whereby autophagy promotes Fas-induced death but not TRAIL-induced death. Our work here establishes a molecular mechanism for an autophagy-dependent switch from apoptosis inhibition to promotion and provides an example whereby stochastic variability in autophagy can determine cell fate. These findings also underscore the importance of autophagy in cancer therapy, specifically in the case of cancers where Fap-1 is implicated 50 and more generally by demonstrating that autophagy can switch from a death promoter to a death inhibitor in different contexts. Present attempts to modulate autophagy in a clinical setting 51 are focused on using autophagy inhibition combined with other anti-cancer drugs and are the focus of over three dozen clinical trials. Such trials should consider the implications of context-specific promotion and inhibition of apoptosis by autophagy.
METHODS
Methods and any associated references are available in the online version of the paper. Immunoblots. Western blotting was performed using standard methods with antibodies in 3% milk in TBS/1%Tween-20 at the above dilutions. Owing to difficulty detecting Fap-1 with the best available antibody, western blots were performed with 50 µg of total protein on an 8% 1.5 mm mini gel; electrophoresis started at 10 milliamps with stepwise 10 milliamp increases in amperage every 10 minutes to 80 milliamps and was run for approximately 2 1/2 hours total, followed by transfer on a semi-dry apparatus for 1.5 h at 15 V. Fap-1 western blots were always run on separate gels from the other proteins in each experiment due to the amount of protein required to detect Fap-1 and the low percentage of gel used to detect this large protein. RNA interference. Protein depletion through RNA-mediated interference (RNAi) was mediated using the pLKO shRNA system (Sigma-Aldrich). Plasmids were obtained from the Functional Genomics Core at the University of Colorado Boulder. Lentiviruses were generated by co-transfection of pLKO-shRNA plasmids with lentiviral plasmids: pMD2G, pRRE and pRSV into 293FT cells by calcium phosphate or polyethyleneimine (PEI). Lentiviruses were collected in highserum media supplemented with sodium pyruvate and 1% BSA at 48 and 72 h following transfection, pooled and frozen at −80 • C for later use. BJAB and Jurkat cells were transduced with lentiviruses by centrifugation at 1,000g for 15 min at room temperature with high-titre virus and 8 µg ml −1 Polybrene (hexadimethrine bromide, Sigma-Aldrich) followed by incubation with virus at 37 • C for 4-6 h. shRNA-transduced cells were selected with 1 µg ml −1 puromycin for 48 h. Knockdown was assessed by western blotting at an appropriate time point each time the experiment was replicated. Lentivirus-transduced cells were passaged fewer than 3 times before performing experiments, to ensure that clonal populations with re-expression of the protein of interest or other compensatory mechanisms were minimized. TRC numbers for shRNAs used here are: Atg5, no. 151474; Atg7, no. 7587; Vps34 no. 196840; p62, no. 7233, no. 7234; Fap-1 (PTPN13) no. 2089, no. 2088; Bid no. 62709. Certain supplemental shRNA experiments used pGIPZ vectors (Thermo Scientific, Rockford, IL): control, RHS4346; Atg12, V2LMM_78431.
Nucleofection. BJAB and Jurkat cells were transfected with an Amaxa nucleofector
and Kit V (Lonza), program C-005 (BJAB) and program X-001 (Jurkat), according to the manufacturer's protocols. Constructs used were: pFlag-PTPN13 (wild-type, CD, PDZ), pEGFP, pEGFP-Atg4b(C74A) and pEGFP-Rab7(Q67L).
Flow cytometry. All flow cytometry experiments were performed in triplicate, using 10-20,000 cells per replicate. All experiments were performed at least three times, usually many more. Tandem labelled mCherry-EGFP-LC3 plasmid containing the hygromycin resistance marker was constructed by restriction enzyme cloning of the hygromycin resistance gene from pBabe-hygro into pBabe-puro-mCherry-GFP-LC3 (Debnath Lab). Retroviruses were generated using GP2-293 cells according to the provider's protocol (Clontech). BJAB and Jurkat cells were transduced according to the spinfection protocol above. A population of cells with intermediate GFP and Cherry expression was obtained by two rounds of flow sorting. HeLa mCherry-GFP-LC3 cells were derived from a single clone. Cells constitutively expressing mCherry-GFP-LC3 were cultured for several days with log-phase growth. The cells were then analysed and sorted on MoFlo XDP-100 or XDP-70 flow cytometers (Beckman Coulter). Dead cells were excluded on the basis of scatter and DAPI exclusion. Flow data were acquired and analysed using Summit v5.1 (Beckman Coulter). Autophagic flux was determined by plotting the ratio of mCherry:GFP. The top and bottom 20% were defined as high-and low-autophagic-flux populations, respectively. These sorted populations were immediately plated for experiments or collected for protein analysis. For cell cycle analysis, cells were incubated in 10 µg ml −1 Hoechst 33342 (Sigma) at 37 • C for 20 min in growth medium, then washed and analysed on the flow cytometer. Some analyses were conducted on a Gallios 571 flow cytometer (Beckman Coulter) fitted with a 561 nm yellow laser. Saponin extraction of non-membrane-bound LC3 for flow cytometric analysis and quantification of autophagosome/autolysosomes was performed according to previously published protocols using 0.2% saponin in PBS (ref. 31).
Cytotoxicity assays. All long-and short-term cytotoxicity assays were performed in triplicate and each experiment was repeated at least three times (with the exception of p62 shRNA no. 34, which was performed only twice). Dose response curves over 4 logs of drug concentration were performed for each experiment to accurately visualize trends and control for experimental variability and lotto-lot variability in Fas ligand and TRAIL. To assess short-term cell survival following 24 h of treatment, cells were plated in 96-well format at 40,000 cells per well for BJAB and 50,000 cells per well for Jurkat, SKW6.4 and CEM-CCRF. TRAIL (R&D Systems) and SuperFas Ligand (Enzo Life Sciences) were prepared according to the manufacturer's instructions before addition to cells. Two hours before the end of the experiment, cells were treated with CellTiter MTS reagent (Promega) according to the manufacturer's instructions. Each plate was incubated at 37 • C for 2-3 h and a Bio-Rad Benchmark Plus Microplate Spectrophotometer (Bio-Rad Laboratories, Hercules) was used to measure absorbance of samples at 490 nm. Long-term growth of suspension cells following treatment was assayed by grow-back. Briefly, cells were treated with Fas ligand as above for 24 h in 96-well format, and then 1 µl was aliquoted into 100 µl growth media without drug or ligand. Cell growth was then monitored over 5-7 days and quantified by MTS.
Apoptosis assays. Flow-sorted BJAB cells (as above) were plated in a 12-well plate at a density of 100,000 cells per well in triplicate, followed by treatment with Fas ligand as above. AnnexinV/DAPI staining was performed by staining cells with AnnexinV-Alexa647 (Invitrogen) according to the manufacturer's protocol with a DAPI concentration of 10 nM. Caspase-3/7 activity was determined using CellEvent Green (Invitrogen) according to the manufacturer's protocol and analysed either by flow cytometry or on an IncuCyte Zoom (Essen Biosystems) live-cell imaging system. These assays were each performed three times and the data herein are from a representative experimental replicate.
Fluorescence microscopy. Cells were sorted for autophagic flux as described above, cytospun onto coated slides, fixed with 4% formaldehyde at room temperature for 10 min, washed and mounted using gelvatol. Epifluorescent images were acquired with Volocity 5 (Perkin Elmer) on a Zeiss Axiovert 200M microscope (Carl Zeiss) outfitted with a ×63 objective. Epifluorescent image analysis and quantification were automated using Volocity 5. Briefly, cell area was quantified by regions of interest as defined by fluorescent intensity threshold 1/2 standard deviation above background and puncta were defined as areas with intensity three standard deviations above background within the defined regions of interest. Field choice and acquisition were not blinded; fields were chosen on the basis of the presence of 1 or more entire cells as detected by Volocity. Automated calculations were validated manually for each image, exported from Volocity and analysed in Excel. Confocal images were acquired on an Olympus FV1000 laser scanning confocal microscope with a ×63 objective. Images were acquired by an individual blinded to the experimental conditions and with no knowledge of the expected outcome. ImageJ v1.46r (NIH) was used to adjust intensity using identical settings for each image and to analyse the raw images. Images used in the figures are representative of trends observed in all of the images obtained. Co-localization images were created using the ImageJ co-localization plugin (http://rsbweb.nih.gov/ ij/plugins/colocalization.html) and quantified by integrated optical density analysis using the ImageJ Measure function.
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Supplementary Figure 1 Method to sort cells with high and low autophagic flux by flow cytometry accurately measures basal and induced autophagic flux. a, Cells constitutively expressing mCherry-GFP-LC3 are sorted based on the relative ratio of mCherry/EGFP fluorescence which changes in response to the pH gradient as autophagosomes fuse with lysosomes to form autolysosomes (autophagic flux). b, BJAB mCherry-GFP-LC3 cells were treated with EBSS (100%) or trehalose (75 mM) for 4 hours followed by flow cytometry for autophagic flux. Data are representative of at least 3 independent experiments. c, HeLa mCherry-GFP-LC3 cells expressing control or Atg5 shRNA were treated with EBSS for 4 hours followed by flow cytometry for autophagic flux. Data are representative of at least 3 independent experiments. d, BJAB mCherry-GFP-LC3 cells were sorted by flow cytometry for high or low autophagic flux, then treated with Lysotracker Blue for 30 min. at 37 °C, followed by flow cytometry (median GFP, mCherry or Lysotracker Blue fluorescence normalized to fold over unsorted control, mean ± s.e.m., n=3 wells). e, BJAB mCherry-GFP-LC3 cells were sorted as in (d) followed by cytoplasmic extraction with 0.1 % saponin to eliminate non-lipidated LC3 1 and flow cytometry to quantitate autophagosome/autolysosome number (normalized fold over unsorted control median GFP or mCherry fluorescence, mean ± s.e.m., n=3 wells). f, Flow cytometry histograms of representative data from (e). Cell viability was then quantitated by MTS absorbance (fold over untreated control, mean ± s.e.m., n=3 wells). b, BJAB cells expressing control or Bid shRNA were treated with autophagy inhibitor chloroquine (25 μM) for 12 hours followed by Fas ligand (4 ng/mL) for 24 hours. Cell viability was then quantitated by MTS (fold over untreated control, mean ± s.e.m., n=3 wells). c, BJAB cells were treated with autophagy inhibitors chloroquine (20 μM) or desmethylclomipramine (DCMI, 10 μM) for 12 hours followed by treatment with the indicated cytotoxic agents for 24 hours. Cells were then assayed for viability by MTS (% of control (no cytotoxic drug), mean ± s.e.m., n=3 wells, *p=0.0024, **p=0.017). d, BJAB cells expressing vector control or the indicated autophagy dominant-negative constructs were treated with Fas ligand (4 ng/mL) for 24 hours; cell viability was then quantitated by MTS absorbance (fold over untreated control, mean ± s.e.m., n=3 wells). Data are representative of 2 independent experiments. e, BJAB cells expressing control or Atg5 shRNA were treated with chloroquine (20 μM) for 12 hours followed by Fas ligand (4 ng/mL) for 24 hours. Cell viability was then quantitated by MTS (fold over no ligand control, mean ± s.e.m., n=3 wells). Data are representative of 3 independent experiments. f, g, BJAB cells were treated with the indicated autophagy inducers overnight (EBSS, 100%; trehalose, 75 mM) followed by treatment with Fas ligand at the indicated concentrations for 24 hours. Cell viability was then quantitated by MTS absorbance. f, MTS data normalized (fold over untreated (no Fas ligand) control, mean ± s.e.m., n=3 wells). g, Raw MTS values (absorbance at 490 nm, mean ± s.e.m., n=3 wells). 
